Feb 28, 2022 / 01:30PM GMT
Operator
Greetings, and welcome to the Aurinia Pharmaceuticals Fourth Quarter and Full Year 2021 Results Conference Call. (Operator Instructions) As a reminder, this conference is being recorded.
I would now like to turn the conference over to your host, Dana Lynch, Aurinia's Director of Corporate Communications and Corporate Affairs. Thank you. You may begin.
Dana Lynch - Aurinia Pharmaceuticals Inc. - Director of Corporate Communications
Thank you, Melissa, and thank you all for joining today's call to discuss Aurinia's 2021 fourth quarter and year-end financial results. Joining me this morning are Peter Greenleaf, President and CEO; and Joe Miller, Chief Financial Officer, who will be leading the call. Other members of the executive team, specifically Max Colao, Chief Commercial Officer; Dr. Neil Solomons, Chief Medical Officer, will be available at the conclusion of our presentation for the Q&A portion of the call.
This morning, we issued a press release announcing our financial results and recent operational highlights and filed of our annual
Q4 2021 Aurinia Pharmaceuticals Inc Earnings Call Transcript
Feb 28, 2022
Already have an account? Log in
Get the full story
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent 
4.6 out of 5 
Trustpilot
Trustpilot
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers